Stem Cell Transplantation
Low dose improves survival in peripheral blood recipients
Published in Blood Weekly, July 10th, 2003
"Allogeneic peripheral blood stem cell transplantation (PBSCT) has emerged as an alternative to bone marrow transplantation," researchers in France explained. However, "PBSCT can be associated with a higher incidence of chronic graft-versus-host disease (cGVHD)."
M. Mohty and colleagues at the Paoli-Calmettes Institute in Marseille "investigated whether there was a correlation between the composition of PBSC grafts (CD34+ and CD3+ cells) and hematological recovery, GVHD, relapse, and relapse-free survival (RFS) after myeloablative HILA-identical sibling...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-07-10)
More Articles from Blood Weekly
- Leukemia Vaccine
Peptide-pulsed dendritic cells produce little clinical effect - Stem Cell Transplantation
CD34+ enrichment doesn't improve elutriated graft outcome in non-cancer patients - Chronic Lymphocytic Leukemia
Stem cell allografts effective after reduced-intensity conditioning - Stem Cell Transplantation
CD34 cell dose has significant impact on outcome of related, unrelated grafts - Umbilical Cord Blood
Phenotype of long-term engrafting cells identified - Anticoagulant Therapy
Argatroban used in bypass surgery can avoid heparin-induced thrombocytopenia - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
